Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study

Fig. 1

Overall survival (OS) of leptomeningeal metastasis (LM) from NSCLC cohort and Kaplan-Meier estimates based on clinical characteristics. a The median OS of all the patients after diagnosis of LM was 8.0 months; b The OS for LM patients with EGFR mutation was significantly improved than those wild-type EGFR (P < 0.001); c The OS for LM patients aged < 53.5 years was significantly extended than those ≥53.5 years (P = 0.041)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us